FTC Releases Second Interim Staff Report on Prescription Drug …
Jan 14, 2025 · The FTC’s latest interim staff report is part of the Commission’s ongoing study of the PBM industry. This report highlights several key insights gained from data and documents …
FTC Releases Interim Staff Report on Prescription Drug Middlemen
The Federal Trade Commission today published an interim report on the prescription drug middleman industry that underscores the impact pharmacy benefit managers (PBMs) have on …
FTC Sues Prescription Drug Middlemen for Artificially Inflating …
Sep 20, 2024 · Today, the Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and …
FTC sues pharmacy benefit managers for inflating price of insulin : …
Sep 21, 2024 · In a new lawsuit filed Friday, the Federal Trade Commission said it's going after one link in the chain: pharmacy benefit managers (PBMs).
FTC Issues PBM Report Signaling Consolidation Is Impacting ...
Jan 22, 2025 · At a public meeting held on January 15, 2025, the Federal Trade Commission (FTC) summarized the Second Interim Staff Report (Second Report) stemming from its …
FTC report: Pharmacy benefit managers profit at expense of ... - CNN
Jul 9, 2024 · Pharmacy benefit managers, which negotiate the terms for prescription drug access for hundreds of millions of Americans, are racking up profits while squeezing patients and …
PBMs made billions marking up specialty drugs by more than …
Jan 14, 2025 · The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying the major industry middlemen generate …
FTC slams pharmacy benefit managers in first report from ongoing ...
Jul 9, 2024 · In the report, the FTC highlights how unchecked consolidation has created a market where the six largest PBMs control almost 95% of the prescriptions filed in the U.S., allowing …
Feds poised to sue pharmacy gatekeepers over high drug costs
Jul 10, 2024 · The Federal Trade Commission is getting ready to sue big health care companies, claiming that they are illegally maximizing profits by steering patients to high-cost drugs, …
How FTC's Battle With PBMs Could Reshape The Pharmaceutical ... - Forbes
Jul 20, 2024 · Now, PBMs are center stage for the FTC. The Federal Trade Commission has turned its attention to these powerful intermediaries and is, according to the Wall Street …